GCG and type 2 diabetes mellitus: Glucagon-like peptide-1 (GLP-1) analogues are approved for the treatment of type 2 diabetes but have recently been suggested to ameliorate degenerative neurological disease and reduce inflammation after ischemic cerebral stroke [13].